ClassID:

96212

C07F9/65522 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Recent Application in this class:
#1
20260028364
2026-01-29

CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY

#2
20260008763
2026-01-08

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#3
20250250292
2025-08-07

DELIVERY SYSTEM TO TARGET GRAM-NEGATIVE BACTERIA

#4
20250170154
2025-05-29

Genistein phosphate derivatives

#5
20250093315
2025-03-20

MOLECULAR SENSORS, METHOD AND KIT FOR THE DETECTION AND QUANTIFICATION OF CARBON DIOXIDE

#6
20250034104
2025-01-30

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#7
20250011768
2025-01-09

Stabilized CRISPR Complexes

#8
20240300987
2024-09-12

TRAP1 INHIBITOR AND USE THEREOF

#9
20240298524
2024-09-05

N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant

#10
20240277851
2024-08-22

siRNA DELIVERY VECTOR

#11
20240217942
2024-07-04

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#12
20240209011
2024-06-27

HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER

#13
20240147841
2024-05-02

Organic Semiconductive Layer Comprising Phosphine Oxide Compounds

#14
20240124503
2024-04-18

HETEROAROMATIC PHOSPHONIUM SALTS AND THEIR USE TREATING CANCER

#15
20240101585
2024-03-28

HETEROAROMATIC PHOSPHONIUM SALTS AND THEIR USE TREATING CANCER

#16
20240101584
2024-03-28

TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES

#17
20240083866
2024-03-14

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#18
20230293522
2023-09-21

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

#19
20230227482
2023-07-20

TETRAHYDROCANNABINOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF

#20
20230192658
2023-06-22

CONJUGATES INCLUDING A DETECTABLE MOIETY

#21
20230130102
2023-04-27

Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER

#22
20220372297
2022-11-24

Water soluble fluorescent or colored dyes and methods for their use

#23
20220331346
2022-10-20

Substituted bicyclic compounds

#24
20220331316
2022-10-20

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

#25
20220281903
2022-09-08

FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES

#26
20220194916
2022-06-23

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#27
20220056436
2022-02-24

Stabilized CRISPR complexes

#28
20210376386
2021-12-02

Modified ionic liquids containing bicyclophosphate moiety

#29
20210261782
2021-08-26

Water soluble fluorescent or colored dyes and methods for their use

#30
20210202842
2021-07-01

N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant

#31
20210047284
2021-02-18

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#32
20200281952
2020-09-10

Substituted bicyclic compounds

#33
20200255461
2020-08-13

Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates

#34
20200247774
2020-08-06

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#35
20200109287
2020-04-09

Water soluble fluorescent or colored dyes and methods for their use

#36
20200085821
2020-03-19

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

#37
20200024248
2020-01-23

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#38
20190315713
2019-10-17

Compounds and uses thereof for detection of target molecules in a sample

#39
20190233387
2019-08-01

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#40
20190211040
2019-07-11

P-chiral phosphine ligands and use thereof for asymmetric synthesis

#41
20190136065
2019-05-09

Compositions comprising a polymeric dye and a cyclodextrin and uses thereof

#42
20190076450
2019-03-14

Substituted bicyclic compounds

#43
20190031637
2019-01-31

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#44
20180372733
2018-12-27

Antibody-nanoparticle conjugates and methods for making and using such conjugates

#45
20180362485
2018-12-20

N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS

#46
20180360857
2018-12-20

Beta-lactamase inhibitors, formulations, and uses thereof

#47
20180337339
2018-11-22

Organic semiconductive layer comprising phosphine oxide compounds

#48
20180311239
2018-11-01

Heteroaryl compounds useful as inhibitors of sumo activating enzyme

#49
20180306792
2018-10-25

Flourescent exomarker probes for hydrogen sulfide detection

#50
20180223102
2018-08-09

Dyes with phosphinic acid, phosphinate, phosphonate and phosphonamidate substituents as auxochromic groups and methods for preparing the same

#51
20180163052
2018-06-14

Water soluble fluorescent or colored dyes and methods for their use

#52
20180086779
2018-03-29

TOCOPHEROL PHOSPHORIC ACID ESTER SALT, METHOD FOR MANUFACTURING THE SAME, AND SKIN EXTERNAL PREPARATION

#53
20170305944
2017-10-26

Method of biotransformation of benzopyrone compounds into the corresponding phosphate-conjugated derivatives

#54
20170304332
2017-10-26

Substituted bicyclic compounds

#55
20170252460
2017-09-07

Functionalizing nanofibres

#56
20170240577
2017-08-24

Antioxidant compound having anti atherosclerotic effect and preparation thereof

#57
20170229670
2017-08-10

COPPER (I) PYRAZOLATE DIMERS FOR ELECTROLUMINESCENT DEVICES

#58
20170216290
2017-08-03

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

#59
20170158723
2017-06-08

Heterocyclic selenamonophosphites protected on a hydroxyl group and processes for preparation thereof

#60
20170158590
2017-06-08

Heterocyclic selenabisphosphites and process for preparation thereof

#61
20170082642
2017-03-23

FLUORESCENT CELL MARKERS

#62
20170042917
2017-02-16

Substituted bicyclic compounds

#63
20170033297
2017-02-02

Condensed cyclic compound and organic light-emitting device including the same

#64
20170002032
2017-01-05

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

#65
20160356782
2016-12-08

Fluorogenic hydrazine-substituted compounds

#66
20160318891
2016-11-03

TONABERSAT PRODRUGS

#67
20160296636
2016-10-13

Functionalizing nanofibres

#68
20160244470
2016-08-25

Antioxidant compound having anti atherosclerotic effect and preparation thereof

#69
20160214955
2016-07-28

Carbon monoxide releasing molecules and associated methods

#70
20160208100
2016-07-21

Water soluble fluorescent or colored dyes and methods for their use

#71
20160184811
2016-06-30

Aryl phosphines with fused ring ortho-alkoxy substitution

#72
20160145280
2016-05-26

Tunable fluorescence using cleavable linkers

#73
20160118599
2016-04-28

Compound and organic light-emitting device including the same

#74
20160116462
2016-04-28

Antibody-nanoparticle conjugates and methods for making and using such conjugates

#75
20160052888
2016-02-25

Substituted bicyclic compounds

#76
20160016928
2016-01-21

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#77
20160009744
2016-01-14

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

#78
20150322034
2015-11-12

Pro-drug compounds

#79
20150239931
2015-08-27

Inhibitors of protein tyrosine phosphatases

#80
20150218193
2015-08-06

Water-soluble derivatives and prodrugs of acacetin and methods of making and using thereof

#81
20150218121
2015-08-06

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#82
20150087620
2015-03-26

Amine compound and use thereof for medical purposes

#83
20150018566
2015-01-15

TUBULIN BINDING AGENTS

#84
20140371480
2014-12-18

Copper catalyzed halogenaton and reaction products

#85
20140343088
2014-11-20

Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof

#86
20140086843
2014-03-27

Bifunctional hydroxy-bisphosphonic acid derivatives

#87
20140079632
2014-03-20

ACTIVITY-BASED PROBES FOR THE UROKINASE PLASMINOGEN ACTIVATOR

#88
20140011773
2014-01-09

Pro-drug Compounds

#89
20130323168
2013-12-05

Agents and methods for visualizing analytes

#90
20130288911
2013-10-31

Fluorogenic hydrazine-substituted compounds

#91
20130203998
2013-08-08

Synthesis of Drug Conjugates Via Reaction With Epoxide-Containing Linkers

#92
20130034854
2013-02-07

Antibody-nanoparticle conjugates and methods for making and using such conjugates

#93
20130018195
2013-01-17

FLUORESCENT CELL MARKERS

#94
20120289484
2012-11-15

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#95
20120283141
2012-11-08

Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest

#96
20120238018
2012-09-20

Caged ceramide-1-phosphate derivatives

#97
20120211082
2012-08-23

PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME

#98
20120197025
2012-08-02

Organophosphorus compounds based on tetraphenol (TP)-substituted structures

#99
20120140439
2012-06-07

Rare-earth complex and uses thereof

#100
20120116079
2012-05-10

Phosphonate fluorescent dyes and conjugates

#101
20120046475
2012-02-23

Palladium phosphine complexes for the telomerization of butadiene

#102
20120041203
2012-02-16

METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM

#103
20110245512
2011-10-06

Hydroxylated contrast enhancement agents

#104
20110245511
2011-10-06

Intermediates for hydroxylated contrast enhancement agents

#105
20110236930
2011-09-29

Chemoselective ligation

#106
20110118482
2011-05-19

Bidentate chiral ligands for use in catalytic asymmetric addition reactions

#107
20110105437
2011-05-05

Mitochondrially delivered anti-cancer compounds

#108
20110054165
2011-03-03

Xanthene dyes

#109
20110028437
2011-02-03

PHOSPHORYLATED PYRONE ANALOGS AND METHODS

#110
20100291547
2010-11-18

Fluorogenic hydrazine-substituted compounds

#111
20100267673
2010-10-21

Protein phosphatase 2A-activating agents

#112
20100261903
2010-10-14

Phosphonate fluorescent dyes and conjugates

#113
20100260682
2010-10-14

Compounds and methods of use thereof for assaying lysophospholipase D activity

#114
20100255521
2010-10-07

Fluorescent substrates for Detecting organophosphatase enzyme activity

#115
20100217006
2010-08-26

Inhibitor of ischemic disorders

#116
20100204183
2010-08-12

Substituted phosphonates and their use in decreasing amyloid aggregates

#117
20100204089
2010-08-12

PHOSPHORYLATED PYRONE ANALOGS AND METHODS

#118
20100203637
2010-08-12

Fluorescent cell markers

#119
20100183517
2010-07-22

Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use

#120
20100174058
2010-07-08

Fluorescent quenching detecting reagents and methods

#121
20100144612
2010-06-10

PHOSPHORYLATED PYRONE ANALOGS AND METHODS

#122
20100105566
2010-04-29

Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest

#123
20100092386
2010-04-15

System for delivering therapeutic agents into living cells and cells nuclei

#124
20100004209
2010-01-07

[(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives

#125
20090163725
2009-06-25

Phosphonic acid diester derivative and method for producing thereof

#126
20090143462
2009-06-04

Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same

#127
20090130051
2009-05-21

Flavonoid compounds and uses thereof

#128
20090069273
2009-03-12

Phosphorylated pyrone analogs and methods

#129
20090068697
2009-03-12

Compounds and methods of use thereof for assaying lysophospholipase D activity

#130
20090004293
2009-01-01

Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers

#131
20080312440
2008-12-18

Synthesis of drug conjugates via reaction with epoxide-containing linkers

#132
20080275005
2008-11-06

MITOCHONDRIALLY TARGETED ANTIOXIDANTS

#133
20080221070
2008-09-11

METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH

#134
20080214811
2008-09-04

XANTHENE DYES

#135
20080214801
2008-09-04

Chemoselective ligation

#136
20080207887
2008-08-28

PHOSPHONYLATED FLUORESCENT DYES AND CONJUGATES

#137
20080076833
2008-03-27

Phosphorylated Polyphenols as Colour-Stable Agents

#138
20070270381
2007-11-22

Mitochondrially targeted antioxidants

#139
20070244075
2007-10-18

Isoflavonoid Prodrugs, Compositons Thereof and Therapeutic Methods Involving Same

#140
20070219165
2007-09-20

Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use

#141
20070172832
2007-07-26

Phosphonate fluorescent dyes and conjugates

#142
20070072832
2007-03-29

Benzopyran derivatives as potassium channel openers

#143
20070049761
2007-03-01

Substituted phosphonate fluorescent sensors and use thereof

#144
20070049556
2007-03-01

Benzopyran derivatives as potassium channel openers

#145
20070043206
2007-02-22

Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol

#146
20070042370
2007-02-22

Fluorescent substrates for detecting organophosphatase enzyme activity

#147
20070037964
2007-02-15

Chemoselective ligation

#148
20070031892
2007-02-08

Coumarin-based amino acids for use in enzyme activity and substrate specificity assays

#149
20070003957
2007-01-04

Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis

#150
20060292589
2006-12-28

Fluorescent quenching detection reagents and methods

#151
20060276658
2006-12-07

Chemoselective ligation

#152
20060199955
2006-09-07

Phosphonylated fluorescent dyes and conjugates

#153
20060160068
2006-07-20

Competitive immunoassay

#154
20060142603
2006-06-29

Transition metal complex and process for producing optically active alcohol

#155
20060128980
2006-06-15

Method for making nitrile compounds from ethylenically unsaturated compounds

#156
20060079486
2006-04-13

Lipopolymer conjugates

#157
20060063867
2006-03-23

Phosphate ester flame retardants from resorcinol-ketone reaction products

#158
20060052645
2006-03-09

Method for producing dialdehydes and or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds

#159
20050250742
2005-11-10

Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)

#160
20050245487
2005-11-03

Mitochondrially targeted antioxidants

#161
20050233469
2005-10-20

Activity-based probes for protein tyrosine phosphatases

#162
20050170363
2005-08-04

Xanthene dyes

#163
20050148032
2005-07-07

Chemoselective ligation

#164
20050124787
2005-06-09

Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol

#165
20050100976
2005-05-12

Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest

#166
20050090431
2005-04-28

Water soluble prodrugs of hindered alcohols

#167
20050010060
2005-01-13

Quinones as disease therapies

#168
16721090
2020-12-15

Beta-lactamase inhibitors, formulations, and uses thereof